KreaMedica

KreaMedica

The firm operates from Montreal with additional presence in Oakland, Palo Alto, Seoul, and Tel Aviv. Its leadership page names five principals — Karl-Rudolf Erlemann, Vik Pham, Christina Wizemann, Francois Duguay, and Dominic Poulin — though titles and founding date remain undisclosed. KreaMedica describes itself as a general contractor for biotech, assembling fit-for-purpose CRO and CMO networks for each engagement rather than maintaining a fixed in-house lab. The company does not publicize a disclosed AUM or deployment figure. KreaMedica's model covers lead candidate selection through non-clinical safety assessments and early clinical trials. Core expertise spans biologic product development, inhalation delivery for respiratory disease, vaccine regulatory pathways, and CNS compound development. The firm claims a network of qualified suppliers from late discovery through clinical needs, and it supplements internal programs with a curated consultant marketplace called KreaConnect, which provides on-demand expertise in regulatory, CMC, pharmacology, toxicology, and clinical advisory. The firm has worked with sponsors including Nocion Therapeutics, Respirion Pharmaceuticals, Cairn Therapeutics, and Adamed Pharma, according to published testimonials. Public numbers are modest but directional: more than 150 development programs executed, over 85 sponsors served, and seed-to-Series A biotech companies among its client base. The firm's website suggests decades of collective experience, though it does not break down headcount. KreaMedica maintains a US phone line in the 617 area code and lists a Waverly Street address in Montreal as its primary contact point. No recent fundraising, acquisition, or significant leadership changes have been reported in the last 24 months. The structural differentiator is the general-contractor posture itself: KreaMedica takes budgetary and monitoring accountability across a program's vendor ecosystem rather than selling billable hours. It promises clients remain in the driver's seat while KreaMedica handles vendor selection, day-to-day oversight, data reliability, and GLP compliance. This construction lets virtual biotechs and small sponsors avoid building in-house CMC, tox, or clinical operations teams, while KreaMedica's cross-functional embedding creates switching costs that pure staffing firms cannot replicate.